The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naïve CD4+ T cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  AIDS (London)

• Publication date

  2017-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/QAD.0000000000001734PMID 29280760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort

  2016cited by this paper
• Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.

  2016cited by this paper
• Immune activation and immune aging in HIV infection

  2016cited by this paper
• Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs.

  2015cited by this paper
• Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients

  2015cited by this paper
• The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation

  2015cited by this paper
• HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

  2015cited by this paper
• The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

  2014cited by this paper
• HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors

  2014cited by this paper
• An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge

  2014cited by this paper
• Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4(+) T lymphocytes.

  2013cited by this paper
• The HIV-1 Tat Protein Induces the Activation of CD8+ T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses

  2013cited by this paper
• Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein

  2013influential reference
• HIV restriction in quiescent CD4+ T cells

  2013cited by this paper
• Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.

  2012influential reference
• The Ins and Outs of HIV‐1 Tat

  2012cited by this paper
• Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells.

  2011cited by this paper
• HIV-Associated Immune Activation: From Bench to Bedside

  2011cited by this paper
• CD4 and CD8 T Cell Immune Activation during Chronic HIV Infection: Roles of Homeostasis, HIV, Type I IFN, and IL-7

  2011cited by this paper
• Antigen-Dependent and -Independent Mechanisms of T and B Cell Hyperactivation during Chronic HIV-1 Infection

  2011cited by this paper
• Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients

  2011cited by this paper
• Measurement of Naive CD4 Cells Reliably Predicts Potential for Immune Reconstitution in HIV

  2010cited by this paper
• Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

  2010cited by this paper
• Associations of Proinflammatory Cytokine Levels With Lipid Profiles, Growth, and Body Composition in HIV-infected Children Initiating or Changing Antiretroviral Therapy

  2010cited by this paper
• Plasma Cytokine Levels in Tanzanian HIV-1-Infected Adults and the Effect of Antiretroviral Treatment

  2009cited by this paper
• Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

  2009influential reference
• Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+ T-Cells

  2009cited by this paper
• Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy

  2009cited by this paper
• The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.

  2008cited by this paper
• Upregulation of PD-1 Expression on HIV-Specific CD8+ T Cells Leads to Reversible Immune Dysfunction

  2007cited by this paper
• Accelerated immune senescence and HIV-1 infection.

  2007cited by this paper
• Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

  2006cited by this paper
• Naïve T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naïve T-Cell Depletion

  2006influential reference
• Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.

  2004cited by this paper
• Multiple effects of HIV‐1 trans‐activator protein on the pathogenesis of HIV‐1 infection

  2004cited by this paper
• HIV-1 Tat Protein Modulates the Generation of Cytotoxic T Cell Epitopes by Modifying Proteasome Composition and Enzymatic Activity1

  2004cited by this paper
• Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

  2004cited by this paper
• Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses1

  2002cited by this paper
• Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

  2002cited by this paper
• HIV‐1 Tat targets microtubules to induce apoptosis, a process promoted by the pro‐apoptotic Bcl‐2 relative Bim

  2002cited by this paper
• T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

  2000cited by this paper
• Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication.

  2000cited by this paper
• Inflamm‐aging: An Evolutionary Perspective on Immunosenescence

  2000cited by this paper
• Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

  2000cited by this paper
• Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.

  1999cited by this paper
• Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.

  1998cited by this paper
• Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells.

  1998cited by this paper
• Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.

  1997cited by this paper
• HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region

  1997cited by this paper
• Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway

  1997cited by this paper
• Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes.

  1996cited by this paper
• An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.

  1995cited by this paper
• Tat‐expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus‐type 1 (HIV ‐1) infection

  1995cited by this paper
• Human immunodeficiency virus type 1 (HIV-1) tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes.

  1993cited by this paper

• Latency-reversing agents: where are we now?

  2025cites this paper
• Unconventional nucleus export and secondary necrosis of human leukemia T lymphocytes (Jurkat cells) transfected with HIV-1 LTR CAT-TAT-72: ultrastructural assessment

  2025cites this paper
• HIV Tat as a latency reversing agent: turning the tables on viral persistence

  2025cites this paper
• Single-cell profiling reveals immunometabolic remodeling with T-cell dysfunction in HIV-1 infected people

  2025cites this paper
• Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis

  2024cites this paper
• Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19

  2024cites this paper
• Regulation of CD4 T Cell Responses by the Transcription Factor Eomesodermin

  2022cites this paper
• T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein.

  2022cites this paper
• New insights into pathogenesis point to HIV-1 Tat as a key vaccine target

  2021cites this paper
• Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines

  2021cites this paper
• Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects

  2021cites this paper
• HIV-1 establishes a sanctuary site in the testis by permeating the BTB through changes in cytoskeletal organization.

  2021cites this paper
• Altered basal lipid metabolism underlies the functional impairment of naive CD8+ T cells in elderly humans

  2020cites this paper
• Modern Approaches in Nanomedicine for NeuroAIDS and CNS Drug Delivery

  2020cites this paper
• HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy

  2020cites this paper
• Prediction of immune pressure on HIV-1 regulatory gene tat by human host through bioinformatics tools

  2020cites this paper
• The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation

  2020cites this paper
• "Inflammescent" CX3CR1+CD57+ CD8 T cells are generated and expanded by IL-15.

  2020cites this paper
• Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

  2019cites this paper
• In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment

  2019cites this paper